CB6使CRISPR-Cas9Ym1

J E Parkinson1,2, G E Baldwin3,4, P H Papotto3,4

  • 1Lydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M139PT, UK. james.parkinson@manchester.ac.uk.

Transgenic research
|September 25, 2025
PubMed
概括

研究人员使用CRISPR-Cas9创建了一个Ym1缺陷的小鼠,克服了基因复制的复杂性. 这种新模型将推进基因酶样蛋白 (CLPs) 和它们在健康和疾病中的作用的研究.